trending Market Intelligence /marketintelligence/en/news-insights/trending/vzugkt7ebdghfoway0zmaw2 content esgSubNav
In This List

Bellicum Pharmaceuticals names CFO

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Bellicum Pharmaceuticals names CFO

Bellicum Pharmaceuticals Inc. named Atabak Mokari CFO, effective Dec. 19.

Mokari was CFO and vice president corporate development at IRIDEX Corp., an ophthalmic medical technology company.

Houston-based Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company that develops novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders.